You are here: Home » News-CM » Companies » News
Business Standard

Dr. Reddys Laboratories launches Tadalafil Tablets in US market

Capital Market 

announced the launch of Tablets USP, a therapeutic equivalent generic version of in the market, approved by the U.

S. (USFDA).

The Adcirca brand and generic had U. S. sales of approximately $490 million MAT for the most recent twelve months ending in November 2018 according to IMS

Dr. Reddy's Tablets are available in 20 mg with 60 count bottle size.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, February 12 2019. 11:11 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU